Physician profile
Sam R Silverblatt
NPI 1891889267
$6,300.10
in general payments reported to CMS, 2019-2025
12 companies · $2,123 in 2025
The $2,123 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $307 · 2021: $358 · 2022: $897 · 2023: $1,037 · 2024: $862 · 2025: $2,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,493 · Travel and Lodging: $1,215 · Entertainment: $307 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,492.99 |
| Travel and Lodging | $1,214.71 |
| Entertainment | $306.79 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $3,656.19 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $442.59 | 2024-2025 | Xdemvy |
| Allergan, INC. | $433.19 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $375.00 | 2022-2024 | Cequa |
| Optos, INC. | $334.54 | 2022-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $288.57 | 2019-2020 | |
| Abbvie INC. | $151.77 | 2023-2025 | Vuity |
| Sight Sciences, INC. | $129.55 | 2025 | Tearcare System |
| Mallinckrodt Hospital Products INC. | $125.00 | 2023 | Acthar |
| Bausch & Lomb Americas INC. | $125.00 | 2024 | Miebo, Xiidra |
| Maculogix, INC. | $123.86 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Silverblatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.